13F Insight vs bioPulse: side-by-side comparison of pricing, ratings, and features on SoftwareVital (2026).
Pricing models differ: 13F Insight is freemium, bioPulse is free. Feature lists share 0 overlapping items across the two listings.
Monitor what institutional investors are buying and selling through AI analysis of SEC filings with alerts for major portfolio moves.
bioPulse is an AI research tool that simplifies clinical trial data and summarizes SEC filings for biotech investors, currently in private beta.
| Attribute | 13F Insight | bioPulse |
|---|---|---|
| Rating | — | — |
| Reviews | — | — |
| Pricing | freemium · $100 | free |
| Votes | 0 | 0 |
| Category | AI For Finance | AI For Data Analytics |
| Feature | 13F Insight | bioPulse |
|---|---|---|
| Free tier available | ||
| no credit ca | ||
| Simplifies complex clinical trial data | ||
| Provides actionable investment insights | ||
| Offers AI-powered analysis | ||
| Identifies potential investment opportunities | ||
| Summarizes SEC filings and competitive landscape | ||
| Currently in private beta (limited access) |